| 发明名称 | Triazine compounds | ||
| 摘要 | The present invention relates to novel triazine compounds of formula (1). The present invention also discloses compounds of formula I along with other pharmaceutical acceptable excipients and use of the compounds to modulate the PI3K/mTOR pathway. | ||
| 申请公布号 | US9630958(B2) | 申请公布日期 | 2017.04.25 |
| 申请号 | US201314416140 | 申请日期 | 2013.07.23 |
| 申请人 | SPHAERA PHARMA PTE. LTD. | 发明人 | Dugar Sundeep;Mahajan Dinesh;Hollinger Peter Frank;Sharma Amit;Tripathi Vinayak;Kuila Bilash |
| 分类号 | C07D413/14;C07D401/04;C07D403/04;A61K31/53;A61K31/5377;A61K31/4427;A61P35/00;C07D417/14;C07D401/14;C07D413/04;C07D417/04;C07D471/04;C07D491/08;C07D498/08 | 主分类号 | C07D413/14 |
| 代理机构 | Foley & Lardner LLP | 代理人 | Foley & Lardner LLP |
| 主权项 | 1. A compoundand salts thereof. | ||
| 地址 | Singapore SG | ||